OEM/ODM Factory Sulfadimidine Sodium 333mg Injection For Animal Healthcare - Closantel Sodium Injection – Jizhong
OEM/ODM Factory Sulfadimidine Sodium 333mg Injection For Animal Healthcare - Closantel Sodium Injection – Jizhong Detail:
closantel sodium injection
properties:
this product is a kind of light yellow transparent liquid.
indications:
this product is a kind of helminthic. it is active against fasciola hepatica,
gastrointestinal eelworms and larvae of arthropods. it is mainly indicated for
diseases caused by fasciola hepatica and gastrointestinal eelworms in cattle
and sheep, estriasis of sheep and etc.
administration and dosage:
subcutaneous or intramuscular injections of a single dose of 2.5 to 5mg/kg
body weight for cattle and 5 to 10 mg/kg body weight for sheep.
adverse reactions: injections are stimulating to some topical tissues.
precautions:
when treating diseases caused by fasciola hepatica it is recommended to
repeat the medication after it has been used for 3 weeks to completely
eliminate immature fasciola.
specification: 100ml: 5g
packing: 100ml/glass bottle
storage:
tightly sealed and store in a cold place protecting from light.
period of validity: 2 years
Product detail pictures:
Related Product Guide:
Well-run products, skilled income group, and better after-sales products and services; We have been also a unified massive family, all people stick with the business price "unification, dedication, tolerance" for OEM/ODM Factory Sulfadimidine Sodium 333mg Injection For Animal Healthcare - Closantel Sodium Injection – Jizhong , The product will supply to all over the world, such as: Brazil, Cannes, Juventus, We have been committed to meet all your needs and solve any technical problems you may encounter with your industrial components. Our exceptional products and vast knowledge of technology makes us the preferred choice for our customers.
By Carey from Estonia - 2018.11.04 10:32
Problems can be quickly and effectively resolved, it is worth to be trust and working together.
By Elsie from USA - 2017.02.18 15:54